Stocks
Kardigan, Inc.KARD
NASDAQHealthcareBiotechnology$13.03
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing therapies for dermatological conditions. Its lead product candidates target unmet needs in acne and other skin disorders, with a pipeline that has attracted attention from investors monitoring the dermatology space. The company's progress through clinical trials and regulatory milestones is a key driver of its valuation.
52W Range: $12.23-$27.00
Congressional Interest in Kardigan, Inc. (KARD)
No congressional trades have been disclosed for Kardigan, Inc. (KARD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading KARD?
No congressional trades found for this stock.